Lexeo Therapeutics Faces Stock Decline Amid Public Offering Announcement

Lexeo Therapeutics' stock has fallen following its announcement of a public offering and private placement aimed at raising capital for its innovative therapies. While this move indicates the company's growth potential and commitment to research, it has raised concerns among investors about share dilution and financial health, impacting market perception and investor confidence.